US FDA Patient Affairs Office Could Accelerate Involvement With 'Central Entry Point'

FDA floats idea of central office to coordinate patient engagement for symbolic as well as practical reasons.

FDA entrance sign 2016

The US FDA is considering elevating patient engagement to a more visible position by establishing a central office for the programs.

The agency said in a Federal Register notice expected to be published March 14 that it is seeking...

More from US FDA

More from Agency Leadership